Variants in the S gene of SARS-CoV-2 have raised concerns regarding trends in viral transmissibility, virulence, and potential evasion of current vaccines.
Symptomatic and asymptomatic infection reduced by 81 percent after partial vaccination and by 91 percent after full vaccination.
Idea backed by more than 60 countries, including the United States.
So far, just over 222 million vaccines have been given in India; less than 5 percent of its population has been fully vaccinated.
Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
Researchers compared the antibody responses of 2 age groups, one younger than 60 years and one older than 80 years, to the first and second doses of the Pfizer-BioNTech COVID-19 vaccination.
The IDSA recommends that antibody therapy should be administered to patients with mild to moderate COVID-19 at high risk for progression to severe disease.
Investigators ask if developing microbiome from face touching can protect against foreign and opportunistic pathogens.
Research into extending the shelf life of the one-dose vaccine is ongoing
Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.